Carmell Therapeutics Corp:企業の製品パイプライン分析2018

◆英語タイトル:Carmell Therapeutics Corp - Product Pipeline Analysis, 2018 Update
◆商品コード:DATA904C12737
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:34
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD1,500 ⇒換算¥222,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥333,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Carmell Therapeutics Corp (Carmell) is a biotechnology company that develops and commercializes bone healing accelerants and tissue healing accelerants. Its pipeline portfolio include adjunctive treatment for long bone fractures in Phase I and Phase II a; and adjunctive treatment for total joint replacement; enhancer and extender for demineralized bone spine; and tissue healing accelerants to reduce surgical site infections in colorectal surgery, sternotomy, cesarean section, and hysterectomy in preclinical phase. Carmell’s pipeline products are based on its patented plasma-based bioactive materials (PBMs). The company caters its products to surgical site infection and orthopedic markets. Carmell is headquartered in Pittsburgh, Pennsylvania, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Carmell Therapeutics Corp
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Carmell Therapeutics Corp Company Overview 5
Carmell Therapeutics Corp Company Snapshot 5
Carmell Therapeutics Corp Pipeline Products and Ongoing Clinical Trials Overview 5
Carmell Therapeutics Corp – Pipeline Analysis Overview 8
Carmell Therapeutics Corp – Key Facts 8
Carmell Therapeutics Corp – Major Products and Services 9
Carmell Therapeutics Corp Pipeline Products by Development Stage 10
Carmell Therapeutics Corp Pipeline Products Overview 12
Bone Healing Accelerant – DBM Spine 12
Bone Healing Accelerant – DBM Spine Product Overview 12
Bone Healing Accelerant – Long Bone (Tibia) Fractures 13
Bone Healing Accelerant – Long Bone (Tibia) Fractures Product Overview 13
Bone Healing Accelerant – Shoulder Repair 14
Bone Healing Accelerant – Shoulder Repair Product Overview 14
Bone Healing Accelerant – Total Joint Replacement 15
Bone Healing Accelerant – Total Joint Replacement Product Overview 15
REPAIR Surgical Scaffold 16
REPAIR Surgical Scaffold Product Overview 16
Tissue Healing Accelerant – C-Section/Hysterectomy 17
Tissue Healing Accelerant – C-Section/Hysterectomy Product Overview 17
Tissue Healing Accelerant – Chronic Wound Beds 18
Tissue Healing Accelerant – Chronic Wound Beds Product Overview 18
Tissue Healing Accelerant – Colorectal Surgery 19
Tissue Healing Accelerant – Colorectal Surgery Product Overview 19
Tissue Healing Accelerant – Partial And Full Thickness Grafts 20
Tissue Healing Accelerant – Partial And Full Thickness Grafts Product Overview 20
Tissue Healing Accelerant – Sternotomy 21
Tissue Healing Accelerant – Sternotomy Product Overview 21
Tissue Healing Accelerant – Surgical Wound Healing 22
Tissue Healing Accelerant – Surgical Wound Healing Product Overview 22
Carmell Therapeutics Corp – Key Competitors 23
Carmell Therapeutics Corp – Key Employees 24
Carmell Therapeutics Corp – Locations And Subsidiaries 25
Head Office 25
Recent Developments 26
Carmell Therapeutics Corp, Recent Developments 26
Jun 22, 2017: Carmell Therapeutics announced the issuance of Canadian Patent No. 2701187 for METHODS AND APPARATUS FOR MANUFACTURING PLASMA BASED PLASTICS 26
Jun 22, 2017: Carmell Therapeutics announced the issuance of Canadian Patent No. 2701187 for Methods and Apparatus for Manufacturing Plasma Based Plastics 26
May 09, 2017: Carmell Therapeutics expands manufacturing capabilities to support Phase III clinical trials 27
Oct 05, 2016: Carmell Therapeutics New Management Team 27
Jun 24, 2016: Carmell announces the awarding of a new U.S. Patent that covers the use of the Company’s plasma-based materials as drug delivery vehicles 28
Apr 07, 2016: Dr. James Hart joins Carmell Therapeutics as new Chief Medical Officer 28
Feb 16, 2016: Carmell Therapeutics Announces Appointment of Randy Hubbell to President and Chief Executive Officer 28
May 15, 2015: Carmell Therapeutics’ Plasma-Based Materials Shown to be Effective Antibiotic Delivery Vehicles 29
Dec 23, 2014: Carmell Therapeutics Ends 2014 with Addition of a New Patent to its Growing Portfolio 29
Nov 14, 2014: Pittsburgh researchers’ bone putty could revolutionize how broken bones mend 30
Appendix 31
Methodology 31
About GlobalData 34
Contact Us 34
Disclaimer 34

List of Tables
Carmell Therapeutics Corp Pipeline Products and Ongoing Clinical Trials Overview 5
Carmell Therapeutics Corp Pipeline Products by Equipment Type 6
Carmell Therapeutics Corp Pipeline Products by Indication 7
Carmell Therapeutics Corp, Key Facts 8
Carmell Therapeutics Corp, Major Products and Services 9
Carmell Therapeutics Corp Number of Pipeline Products by Development Stage 10
Carmell Therapeutics Corp Pipeline Products Summary by Development Stage 11
Bone Healing Accelerant - DBM Spine - Product Status 12
Bone Healing Accelerant - DBM Spine - Product Description 12
Bone Healing Accelerant - Long Bone (Tibia) Fractures - Product Status 13
Bone Healing Accelerant - Long Bone (Tibia) Fractures - Product Description 13
Bone Healing Accelerant - Shoulder Repair - Product Status 14
Bone Healing Accelerant - Shoulder Repair - Product Description 14
Bone Healing Accelerant - Total Joint Replacement - Product Status 15
Bone Healing Accelerant - Total Joint Replacement - Product Description 15
REPAIR Surgical Scaffold - Product Status 16
REPAIR Surgical Scaffold - Product Description 16
Tissue Healing Accelerant - C-Section/Hysterectomy - Product Status 17
Tissue Healing Accelerant - C-Section/Hysterectomy - Product Description 17
Tissue Healing Accelerant - Chronic Wound Beds - Product Status 18
Tissue Healing Accelerant - Chronic Wound Beds - Product Description 18
Tissue Healing Accelerant - Colorectal Surgery - Product Status 19
Tissue Healing Accelerant - Colorectal Surgery - Product Description 19
Tissue Healing Accelerant - Partial And Full Thickness Grafts - Product Status 20
Tissue Healing Accelerant - Partial And Full Thickness Grafts - Product Description 20
Tissue Healing Accelerant - Sternotomy - Product Status 21
Tissue Healing Accelerant - Sternotomy - Product Description 21
Tissue Healing Accelerant - Surgical Wound Healing - Product Status 22
Tissue Healing Accelerant - Surgical Wound Healing - Product Description 22
Carmell Therapeutics Corp, Key Employees 24
Glossary 33

List of Figures
Carmell Therapeutics Corp Pipeline Products by Equipment Type 6
Carmell Therapeutics Corp Pipeline Products by Development Stage 10

★海外企業調査レポート[Carmell Therapeutics Corp:企業の製品パイプライン分析2018]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Equifax Inc.:企業の戦略・SWOT・財務分析
    Equifax Inc. - Strategy, SWOT and Corporate Finance Report Summary Equifax Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Rosenergoatom Concern:電力:M&Aディール及び事業提携情報
    Summary Rosenergoatom Concern (Rosenergoatom) is a subsidiary of Atomenergoprom, which is electric power generation company, mainly supplying electrical and thermal energy in Russia. The company’s major activities include design, construction, operation and decommissioning of nuclear power plants. T …
  • WesternZagros Resources Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary WesternZagros Resources ULC (WesternZagros), formerly WesternZagros Resources Ltd, a subsidiary of Crest Energy International Ltd, is an oil and gas company that acquires, develops, explores and produces crude oil and natural gas. The company holds production sharing contracts with the Kurdi …
  • Monsoon Accessorize Ltd:企業の戦略・SWOT・財務分析
    Monsoon Accessorize Ltd - Strategy, SWOT and Corporate Finance Report Summary Monsoon Accessorize Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Cyxone AB (CYXO):製薬・医療:M&Aディール及び事業提携情報
    Summary Cyxone AB (Cyxone) is a biopharmaceutical company that develops cyclotide drugs for immune-related diseases. The company develops T20K, a compound to inhibit pro-inflammatory cytokines, such as IL2 that helps to reduce clinical symptoms in an animal model for multiple sclerosis after oral ad …
  • TPG Telecom Ltd (TPM):企業の財務・戦略的SWOT分析
    TPG Telecom Ltd (TPM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • InsuLine Medical Ltd (INSL):医療機器:M&Aディール及び事業提携情報
    Summary InsuLine Medical Ltd (InsuLine Medical) is a medical device company that develops, manufactures and markets device which enables patients on intensive insulin therapy. The company offers products such as InsuPad and InsuPatch which are designed to improve the current meal-time insulin therap …
  • Kerecis ehf:医療機器:M&Aディール及び事業提携情報
    Summary Kerecis ehf (Kerecis) is a medical device company that provides products that treats chronic wounds and damaged tissue. The company’s flagship product includes Kerecis Omega3 fish-skin acellular dermal matrix transplantation technology is intended for use in products to treat acute, chronic …
  • Regenicin Inc (RGIN):企業の財務・戦略的SWOT分析
    Summary Regenicin Inc (Regenicin), formerly Windstar Inc is a biotechnology company that develops regenerative cell therapies. The company offers NovaDerm, a tissue-engineered skin prepared from autologous skin cells. Its NovaDerm technology uses the patient’s own skin cells to generate living, tiss …
  • Wellington Management Company LLP:企業のM&A・事業提携・投資動向
    Wellington Management Company LLP - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Wellington Management Company LLP Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mer …
  • Konami Holdings Corp:企業の戦略・SWOT・財務情報
    Konami Holdings Corp - Strategy, SWOT and Corporate Finance Report Summary Konami Holdings Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Inter Parfums SA:企業の戦略・SWOT・財務情報
    Inter Parfums SA - Strategy, SWOT and Corporate Finance Report Summary Inter Parfums SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Shoprite Holdings Ltd:企業の戦略・SWOT・財務情報
    Shoprite Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Shoprite Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Denali Therapeutics Inc (DNLI):製薬・医療:M&Aディール及び事業提携情報
    Summary Denali Therapeutics Inc (Denali Therapeutics) is a clinical-stage biopharmaceutical company that focuses on the development of therapeutics for the treatment of neurodegenerative diseases. The company’s proprietary drug delivery platform technologies include antibody transport vehicle and en …
  • Power Assets Holdings Ltd (6):石油・ガス:M&Aディール及び事業提携情報
    Summary Power Assets Holdings Limited (Power Assets) a subsidiary of CK Infrastructure Holdings Limited, is an investment holding company. The company through its subsidiaries, joint ventures, and affiliates, invests in power and utility-related businesses. The company has interests in electricity g …
  • Particle Sciences Inc-製薬・医療分野:企業M&A・提携分析
    Summary Particle Sciences Inc (Particle Sciences), a subsidiary of The Lubrizol Corp is a contract research organization that offers complete formulation, analytic, bioanalytic and clinical trial material manufacturing solutions. The organization concentrates on BCS II/III/IV molecules, biologics an …
  • RF Surgical Systems Inc-医療機器分野:企業M&A・提携分析
    Summary RF Surgical Systems Inc (RF Surgical Systems), a subsidiary of Medtronic Plc is a medical equipment company that provides retained surgical sponge detection system. The company’s products include RF assure delivery system, RF assure detection system X, and RFDETECT premium. Its RF assures de …
  • Microbion Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary Microbion Corp (Microbion) is a clinical stage biopharmaceutical company that develops therapeutic products. The company develops products for the treatment of chronic infections and antibiotic-resistant infections. It develops environmentally responsible solutions to prevent microbial biofi …
  • Composites Technology Research Malaysia Sdn. Bhd.:企業の戦略・SWOT・財務情報
    Composites Technology Research Malaysia Sdn. Bhd. - Strategy, SWOT and Corporate Finance Report Summary Composites Technology Research Malaysia Sdn. Bhd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structur …
  • Randstad Holding nv:企業のM&A・事業提携・投資動向
    Randstad Holding nv - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Randstad Holding nv Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆